These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9441052)

  • 1. Successful management of a national tuberculosis programme under conditions of war.
    Heldal E; Cruz JR; Arnadottir T; Tardencilla A; Enarson DA
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):16-24. PubMed ID: 9441052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National tuberculosis programme review: experience over the period 1990-95.
    Pio A; Luelmo F; Kumaresan J; Spinaci S
    Bull World Health Organ; 1997; 75(6):569-81. PubMed ID: 9509630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-course tuberculosis chemotherapy in rural Somalia.
    Agutu WO
    East Afr Med J; 1997 Jun; 74(6):348-52. PubMed ID: 9487394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis control in remote districts of Nepal comparing patient-responsible short-course chemotherapy with long-course treatment.
    Jochem K; Fryatt RJ; Harper I; White A; Luitel H; Dahal R
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):502-8. PubMed ID: 9487447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DOTS in Cambodia. Directly observed treatment with short-course chemotherapy.
    Norval PY; San KK; Bakhim T; Rith DN; Ahn DI; Blanc L
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):44-51. PubMed ID: 9562110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cohort analyses of the treatment of smear-positive pulmonary tuberculosis patients under programme conditions in Korea, 1983-1994.
    Hong YP; Kim SJ; Lew WJ; Lee SH; Lee EK
    Int J Tuberc Lung Dis; 1998 May; 2(5):365-71. PubMed ID: 9613631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decentralizing tuberculosis treatment: follow-up of patients during the transitional period.
    Arnadottir T; Phongosa B; Chittamany P; Soukaseum H
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):609-14. PubMed ID: 12102300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low failure rate in standardised retreatment of tuberculosis in Nicaragua: patient category, drug resistance and survival of 'chronic' patients.
    Heldal E; Arnadottir T; Cruz JR; Tardencilla A; Chacon L
    Int J Tuberc Lung Dis; 2001 Feb; 5(2):129-36. PubMed ID: 11258506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOT for patients with limited access to health care facilities in a hill district of eastern Nepal.
    Wares DF; Akhtar M; Singh S
    Int J Tuberc Lung Dis; 2001 Aug; 5(8):732-40. PubMed ID: 11495264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of different subgroups of smear-positive retreatment patients under RNTCP in rural West Bengal, India.
    Mukherjee A; Sarkar A; Saha I; Biswas B; Bhattacharyya PS
    Rural Remote Health; 2009; 9(1):926. PubMed ID: 19260766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors determining the outcome of treatment of adult smear-positive tuberculosis cases in The Gambia.
    Lienhardt C; Manneh K; Bouchier V; Lahai G; Milligan PJ; McAdam KP
    Int J Tuberc Lung Dis; 1998 Sep; 2(9):712-8. PubMed ID: 9755924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a unified treatment regimen for all new cases of tuberculosis using guardian-based supervision.
    Banerjee A; Harries AD; Mphasa N; Nyirenda TE; Veen J; Ringdal T; Van Gorkom J; Salaniponi FM
    Int J Tuberc Lung Dis; 2000 Apr; 4(4):333-9. PubMed ID: 10777082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost of tuberculosis to patients in Sierra Leone's war zone.
    Gibson N; Boillot F; Jalloh H
    Int J Tuberc Lung Dis; 1998 Sep; 2(9):726-31. PubMed ID: 9755926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collaboration between private pharmacies and national tuberculosis programme: an intervention in Bolivia.
    Lambert ML; Delgado R; Michaux G; Vols A; Speybroeck N; Van der Stuyft P
    Trop Med Int Health; 2005 Mar; 10(3):246-50. PubMed ID: 15730509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcome of neuro tuberculosis patients put on DOTS--an observation study from the field.
    Venugopal K; Sreelatha PR; Philip S; Kumar V
    Indian J Tuberc; 2008 Oct; 55(4):199-202. PubMed ID: 19295107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
    Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis: a six-month cure.
    Chaulet P
    World Health Forum; 1989; 10(1):116-22. PubMed ID: 2665766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis control programme in Beijing.
    Zhang LX; Kan GQ
    Tuber Lung Dis; 1992 Jun; 73(3):162-6. PubMed ID: 1421349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.